Keywords: BALF; lung bronchoalveolar lavage fluids; CP; curcumin powder; H&E; hematoxylin and eosin; DPI; dry powder inhaler; DMSO; dimethyl sulphoxide; FPF; fine particle fraction; HPLC; high performance liquid chromatography; LCD; liposomal curcumin dry powder in
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ALG; alginate; Cm; capreomycin; CHI; chitosan; DPIs; dry powder inhalers; E; ethambutol; EC; ethyl cellulose; ECM; extracellular matrix; Eto; ethionamide; FPF; fine particle fraction; HA; hyaluronic acid; HIP/PCA; hydrophobic ion-pairing/precipitation wit
Keywords: PTX; paclitaxel; BSA; bovine serum albumin; MPs; microparticles; DPs; dry powders; PTX-BSA-MPs; PTX loaded BSA MPs; PTX-BSA-MPs-DPs; DPs containing PTX-BSA-MPs; PTX-BSA-MPs-DPs (0.5â¯Î¼m), PTX-BSA-MPs-DPs, 0.5â¯Î¼m; DPs containing 0.5â¯Î¼m PTX-BSA-MPs;
Keywords: DPI; Dry powder inhaler; CF; cystic fibrosis; COPD; chronic obstructive pulmonary disease; pMDIs; pressurized metered dose inhalers; TB; tuberculosis; VdW; Van der Waals; FPF; fine particle fraction; MMAD; mass median aerodynamic diameter; LPPs; large por
Keywords: Tobramycin; Sodium stearate; Particle engineering; RS01 inhaler; Dry powder inhaler; High doses; In vivo inhalation; CF; cystic fibrosis; ED; emitted dose; FPD; fine particle dose; FPF; fine particle fraction; MMAD; mass median aerodynamic diameter; PA; P
Keywords: Cipro; Ciprofloxacin hydrochloride monohydrate; DPI; dry powder inhaler; DVS; dynamic vapor sorption; ED; emitted dose; FPF; fine particle fraction; FTIR; Fourier transform infrared spectroscopy; Lac; lactose; Leu; l-leucine; Man; mannitol; MSLI; Multi-St
Keywords: dry powder inhaler (DPI); force control agent (FCA); blending method; dispersibility; next generation impactor (NGI); single particle aerosol mass spectrometry (SPAMS); time-of-flight secondary ion mass spectrometry (ToF-SIMS); AFM; atomic force microscop
Keywords: TB; tuberculosis; HIV; human immunodeficiency virus; DPI; dry powder inhaler; AIDS; acquired immunodeficiency syndrome; WHO; world health organization; Mtb; Mycobacterium tuberculosis; AM; alveolar macrophage; PTB; pulmonary TB; EPTB; extra pulmonary TB;
Keywords: tuberculosis; ethionamide; porous particles; bioavailability; pharmacokinetics and pulmonary absorption; AUC; area under the curve; BAL; bronchoalveolar lavage; CL; apparent total body clearance; CV%; coefficient of variation; DPAG; dry powder aerosol gen
Keywords: AuNPs; GNPs: gold nanoparticles; YIGSR; laminin peptide (Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg); SASD; supercritical assisted spray drying; CHT; chitosan; CHT-GNP; CHT bearing different formulations of gold nanoprobes; FPF; fine particle fraction; scCO2; su
Keywords: CH; ciprofloxacin hydrochloride; EF; emitted fraction; FPF; fine particle fraction; GA; L glutamic acid; GSD; geometric standard deviation; IOG; incidence of growth; MBEC; minimum biofilm eradication concentration; MHB; Mueller Hinton Broth; MMAD; mass me
Keywords: AUC; Area under the ROC curve; ACE; Average causal effect; CABG; Coronary artery bypass graft; CHD; Coronary heart disease; CRP; C-reactive protein; DA; Discriminatory accuracy; FPF; False positive fraction; HR; Hazard ratios; HDL; High-density lipoprotei
Keywords: Cinnabar; α-HgS; Cold Vapor Atomic Absorption Spectroscopy; CVAAS; Dissolved organic carbon; DOC; Dissolved organic matter; DOM; Elemental mercury; Hg(0); Fine particulate fraction; FPF; Fine-grained-creek-sediment; FGS; Gaseous elemental mercury; GEM; G
Keywords: DPI; Dry powder inhaler; DTPA; Diethylenetriaminepentaacetic acid; FPF; Fine particle fraction; FEV1; Forced expiratory volume in 1Â s; MMI; Marple Miller Impactor; MSLI; Multi-Stage Liquid Impinger; MMAD; Mass median aerodynamic diameter; PIFR; Peak inha
Keywords: AM; alveolar macrophages; ANOVA; analysis of variance; ATR-FTIR; attenuated total reflectance Fourier transform infrared spectroscopy; DPPC; 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine; DSC; differential scanning calorimetry; DSPE-PEG2k; 1,2-distearo
Keywords: COPD; chronic obstructive pulmonary diseases; dA; aerodynamic diameter; dA,theory; theoretical aerodynamic diameter; dG; geometric diameter; DI; dispersibility index; DPI; dry powder inhaler; DXT; dextran sulfate; ED; emitted dose; FPF; fine particle frac
Keywords: API; active pharmaceutical ingredient; Cmax; maximum plasma concentration; CQA; critical quality attribute; CPP; critical process parameter; EMA; European Medicines Agency; FDA; U.S. Food and Drug Administration; FPF; fine particle fraction; ICH; Internat
Keywords: API; active pharmaceutical ingredient; DPI; dry powder inhaler; DSC; differential scanning calorimetry; ED; emitted dose; FPD; fine-particle dose; FPF; fine-particle fraction; HBCD; highly branched cyclic dextrin; HPLC; high-performance liquid chromatogra
Keywords: AFM; atomic force microscopy; API; active pharmaceutical ingredient; CA; contact angle; CAB; adhesive-cohesive balance; COPD; chronic obstructive pulmonary disease; DMT; Derjaguin-Muller-Toporov; DPI; dry powder inhaler; FPF; fine particle fraction;
Keywords: high efficiency DPI; excipient enhanced growth (EEG) delivery; respiratory drug delivery; 3D rod array; PTFE coating; flow rate effects; multiple formulations; computational fluid dynamics (CFD); non-dimensional specific dissipation (NDSD); in vitro inhal
Keywords: API; active pharmaceutical ingredient; AUC; area under the curve; BSA; bovine serum albumin; Cmax; peak concentration; COPD; chronic obstructive pulmonary disease; DPI; dry powder inhaler; DPPC; dipalmitoylphosphatidylcholine; ED; emitted dose; EMA; Europ
Keywords: ARDS; acute respiratory distress syndrome; Asn; asparagine; BSA; bovine serum albumin; CD; cyclodextrin; COPD; chronic obstructive pulmonary disease; dae; diameter of the particles; DPI; dry powder inhaler; DPPC; dipalmitoylphosphatidylcholine; DSPC; dist
InVitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator
Keywords: inhalation flow pattern; dry powder inhalers; pressurized metered dose inhalers; inhalation performance; ACI; Andersen cascade impactor; API; active pharmaceutical ingredient; DPIs; dry powder inhalers; FIR; flow increase rate; FPF; fine particle fraction
Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
Keywords: Idiopathic Pulmonary fibrosis; Budesonide; Colchicine; Liposomal dry powder inhaler; Pulmonary drug delivery; BLM; Bleomycin; DE; Drug entrapment; DPI; Dry Powder Inhaler; EPC; Egg phosphatidyl choline; FPF; Fine particle fraction; HDPE; High density poly
Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation
Keywords: AE; aeration energy; AIF; angle of internal friction; API; active pharmaceutical ingredient; APSD; aerodynamic particle-size distribution; BD; bulk density; BFE; basic flow energy; CI; Carr's index; COPD; chronical obstructive pulmonary disease; CPH; ca
Betaine or folate can equally furnish remethylation to methionine and increase transmethylation in methionine-restricted neonates
Keywords: folate; 5-methyl-tetrahydrofolate; BHMT; betaine:homocysteine methyltransferase; CBS; cystathionine beta-synthase; DMG; dimethylglycine; FPF; fraction of product flux; FNC; fractional net conversion; Hcy; homocysteine; MD-; methyl-deplete diet; MSyn; meth
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products
Keywords: Pulmonary delivery; Dry powder inhalation; Solubility; Dissolution methods; Biopharmaceutical classification; API; Active pharmaceutical ingredient; ACI; Andersen cascade impactor; ALF; alveolar lung fluid; BCS; Biopharmaceutics Classification System; iBC
Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler
Keywords: ACI; Andersen Cascade Impactor; DPIs; dry powder inhalers; FPD; fine particle dose; FPF; fine particle fraction; HPLC; high performance liquid chromatography; IFR; inhalation flow rate; MIF; maximum inhalation flow; IT; inhalation time; IV; inhaled volume
Self-micellizing solid dispersion of cyclosporine A for pulmonary delivery: Physicochemical, pharmacokinetic and safety assessments
Keywords: AUC; area under the curve of blood concentration versus time curve; BALF; bronchoalveolar lavage fluid; BUN; blood urea nitrogen; Cmax; maximum concentration; CsA; cyclosporine A; CsA-RP; amorphous cyclosporine A-based respirable powder; FPD; fine particl
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns
Keywords: Familial pulmonary fibrosis; High resolution computed tomography; Idiopathic pulmonary fibrosis; Pulmonary function tests; FPF; Familial pulmonary fibrosis; HRCT; High Resolution Computed Tomography; PFT; Pulmonary function tests; BAL; Bronchoalveolar lav
Inhalable oridonin-loaded poly(lactic-co-glycolic)acid large porous microparticles for in situ treatment of primary non-small cell lung cancer
Keywords: BSA; bovine serum albumin; DAB; 3,3ʹ-diaminobenzidine; DAPI; 4ʹ,6-diamidino-2-phenylindole; DPI; dry powder inhalation; EGFR; epidermal growth factor receptor; FPF; fine particle fraction; HPLC; high performance liquid chromatography; HRP; horseradish p
Evaluation of highly branched cyclic dextrin in inhalable particles of combined antibiotics for the pulmonary delivery of anti-tuberculosis drugs
Keywords: API; active pharmaceutical ingredient; βCD; β-cyclodextrin; BET; Brunauer-Emmett-Teller; DPI; dry powder-inhaler; ED; emitted dose; FPD; fine-particle dose; FPF; fine-particle fraction; HBCD; highly branched cyclic dextrin; HPLC; high performance li
Impact of capillary flow hydrodynamics on carrier-mediated transport of opioid derivatives at the blood-brain barrier, based on pH-dependent Michaelis-Menten and Crone-Renkin analyses
Keywords: ABL; aqueous boundary layer adjacent to the cell surface (including glycocalyx); CM/PD; carrier-mediated (saturable)/lipoidal passive diffusion (non-saturable); Daq; aqueous diffusivity (cm2·sâ 1); Fpf; cerebrovascular flow velocity of perfusion/injec
Optimization of Acetalated Dextran-Based Nanocomposite Microparticles for Deep Lung Delivery of Therapeutics via Spray-Drying
Keywords: nanocomposite microparticles; pulmonary delivery; design of experiment; spray-drying; particle engineering; Ac-Dex; acetalated dextran; CUR; curcumin; CAC; cyclic acetal coverage; DOE; design of experiment; DSC; differential scanning calorimetry; DMSO; di
An in vitro and in silico study of the impact of engineered surface modifications on drug detachment from model carriers
Keywords: AFM; atomic force microscopy; API; active pharmaceutical ingredient; APSD; aerodynamic particle size distribution; CFD; computational fluid dynamics; DPIs; dry powder inhalers; ED; emitted dose; FPD; fine particle dose; FPF; fine particle fraction; GP; Ga
Application of combinational supercritical CO2 techniques to the preparation of inhalable particles
Keywords: Supercritical CO2; Dry powder inhaler; Submicron-sized particles; Poorly water-soluble drug; API; active pharmaceutical ingredient; DPI; dry powder inhaler; DSC; differential scanning calorimetry; ED; emitted dose; FPF; fine particle fraction; HPLC; high
Carrier-free high-dose dry powder inhaler formulation of ibuprofen: Physicochemical characterization and in vitro aerodynamic performance
Keywords: Ibuprofen (PubChem CID: 3672); Tween 20 (PubChem CID: 443314); sodium dodecyl sulfate (PubChem CID: 3423265); IBU; ibuprofen; GI; gastrointestinal; SEM; scanning electron microscopy; SSA; specific surface area; FT-IR; Fourier transform infrared spectrosco
Exome Sequencing Identifies Mutant TINF2 in a Family With Pulmonary Fibrosis
Keywords: FPF; familial pulmonary fibrosis; IPF; idiopathic pulmonary fibrosis; PCR; polymerase chain reaction;
“Pierce and inhale” design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs
Keywords: AR; aerolizer; DD; delivered dose; DPI; dry powder inhaler; FPD; fine particle dose; FPF; fine particle fraction; HH; HandiHaler; MMAD; mass median aerodynamic diameter; NGI; next generation impactor; RF; respirable fraction; TS; turbospin; RS01; HandiHal
Flupyradifurone (Sivantoâ¢) and its novel butenolide pharmacophore: Structural considerations
Keywords: ACh; acetylcholine; BgTx; bungarotoxin; CNS; central nervous system; DFT; density functional theory; FPF; flupyradifurone; IMD; imidacloprid; IRM; insect resistance management; IRAC; Insecticide Resistance Action Committee; nAChR; nicotinic acetylcholine
Effects of inhalable microparticle of flower of Lonicera japonica in a mouse model of COPD
Keywords: ACI; Anderson cascade impactor; BALF; bronchoalveolar fluid; COPD; chronic obstructive pulmonary disease; CSS; cigarette smoke solution; FBS; fetal bovine serum; FPF; fine particle fraction; FLJ; flower of Lonicera japonica; FLJmp; FLJ microparticle; H&E;
Constant size, variable density aerosol particles by ultrasonic spray freeze drying
Keywords: da; aerodynamic diameter; dg; geometric diameter; Ï; density; dmode; diameter corresponding to the mode of the particle size distribution; BSA; bovine serum albumin; DPI; dry powder inhaler; FPF; Fine Particle Fraction; LN2; liquid nitrogen; NGI; Next Ge
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells
Keywords: CF; cystic fibrosis; ACI; Andersen cascade impactor; CFTR; cystic fibrosis transmembrane conductance regulator; DPI; dry powder inhaler; ED; emitted dose; FPD; fine particle dose; FPF; fine particle fraction; G; gentamicin sulfate; IPA; isopropyl alcohol;
Inhaled extended-release microparticles of heparin elicit improved pulmonary pharmacodynamics against antigen-mediated airway hyper-reactivity and inflammation
Keywords: PLGA; Poly (d,l-lactide-co-glycolide); DCM; dichloromethane; OVA; Ovalbumin; AHR; airway hyper-reactivity; BAL; bronchoalveolar lavage; sGaw; Airway conductance.; NGI; Next Generation Impactor; MMAD; mass median aerodynamic diameter; GSD; Geometric Standa
Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties
Keywords: API; active pharmaceutical ingredient; CI; Carr compressibility index; dae; aerodynamic diameter; DPI; dry powder for inhalation; f2; the similarity factor; FPD; fine particle dose; FPF; fine particle fraction; GRAS; generally recognized as safe; HPLC-UV;
Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation
Keywords: AFM; atomic force microscopy; ANOVA; analysis of variance; ED; emitted dose; FL; fine lactose; FPF; fine particle fraction; HPLC; high performance liquid chromatography; SEM; scanning electron microscopy; SX; salmeterol xinafoate; TSI; twin-stage impinger
Preparation and properties of inhalable nanocomposite particles: Effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles
Keywords: PLGA; Decomposition; Nanoparticle; Nanocomposite; Spraydry; Inhalation; FPF
Fluticasone propionate plasma concentration and systemic effect: Effect of delivery device and duration of administration
Keywords: Pharmacokinetics; fluticasone propionate; metered dose inhaler; dry powder inhaler; cortisol suppression; drug accumulation; steady state; AUC; Area under the curve; AUC0ât; Area under the curve from 0 to time t; CFC; Chlorofluorocarbon; DICE; Dose of I